Anti-TIGIT antibody [4D4]
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Armenian hamster Recombinant Monoclonal TIGIT antibody. Suitable for Flow Cyt, I-ELISA and reacts with Mouse, Recombinant full length protein - Mouse samples.
View Alternative Names
Vstm3, Tigit, T-cell immunoreceptor with Ig and ITIM domains, V-set and transmembrane domain-containing protein 3
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-TIGIT antibody [4D4] (AB289547)
Flow cytometric analysis of mouse splenocytes treated with 2.5 μg/ml Concanavalin A (ConA) for 72h labelling TIGIT with ab289547 at 1/1000 dilution (Right) compared with a American Hamster monoclonal IgG isotype control (Left). A Goat anti American Hamster IgG at 1/500 dilution was used as the secondary antibody.
- I-ELISA
Supplier Data
Indirect ELISA - Anti-TIGIT antibody [4D4] (AB289547)
Indirect ELISA antibody dose-response curve using ab289547 between 0-2000 ng/mL. Antigen concentration of 1000 ng/mL. An alkaline phosphatase-conjugated goat anti-American Hamster IgG (H+L) at 1/1000 dilution was used as the secondary antibody.
Related conjugates and formulations (1)
-
Anti-TIGIT antibody [4D4] (BSA and Azide free)
Reactivity data
Product details
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TIGIT acts as an inhibitory receptor modulating immune responses. It belongs to the CD28 family and binds to poliovirus receptor (PVR) and nectin-2 on antigen-presenting cells. This interaction inhibits T cell activation and proliferation and increases Treg cell activity maintaining immune homeostasis. TIGIT forms a complex with other inhibitory receptors like PD-1 2B4 and CD96 to further regulate immune functions.
Pathways
The interaction of TIGIT with its ligands significantly affects the immune checkpoint pathway. This involvement regulates T cell and NK cell activity. TIGIT is related to CD226 (DNAM-1) which competes for binding to its ligands influencing cellular signaling pathways. Through these pathways TIGIT signals through the downstream SHP-1 and SHP-2 proteins affecting immune cell signaling and response.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com